Raymond James Financial Inc Dexcom Inc Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Dexcom Inc stock. As of the latest transaction made, Raymond James Financial Inc holds 2,723,969 shares of DXCM stock, worth $241 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,723,969Holding current value
$241 Million% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding DXCM
# of Institutions
1,040Shares Held
356MCall Options Held
5.51MPut Options Held
5.61M-
Vanguard Group Inc Valley Forge, PA47.4MShares$4.19 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$3.05 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.59 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.47 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$1.29 Billion0.9% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $34.1B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...